Eccogene announced Michael R. Wiley, Ph.D. joined Scientific Advisory Board
Shanghai, China, May 21, 2020 –Eccogene, Inc., a research driven biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced today the addition of Michael R. Wiley, Ph.D., to its scientific advisory board.Dr. Wiley earned his PhD in chem